Skip to main content
Premium Trial:

Request an Annual Quote

Cenix Moves Operations to New BioInnovation Center

NEW YORK, May 20 (GenomeWeb News) - Cenix Bioscience announced this week that it has moved operations into new facilities located within Dresden's BioInnovationCenter.

 

The company formerly was headquartered within the Max Planck Institute of Molecular Cell Biology and Genetics, one of Cenix's parent institutes.

 

The new location, said Cenix, includes more than 800 square meters of space where its expanding RNA-related research services may be conducted.

 

"The opportunity to grow up and mature as a company within the MPI-CBG has been an exceptional privilege and a true joy, for which we at Cenix are very thankful," Cenix CEO and CSO Christophe Echeverri said in a statement. "The new location is only two blocks away from MPI-CBG, so we look forward to maintaining our existing tight contacts there and also adding an important new dimension to the growing life science research landscape in Dresden."

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.